Dave Hallett is the founder of Exscientia. Latest round: Growth. Backed by Recursion Pharmaceuticals. Based in Dundee, Scotland.
Dave Hallett is a co-founder of Exscientia, an AI-driven drug design company that originated as a spin-out from the University of Dundee in 2012. He served as the Chief Operating Officer, a role he assumed in 2020. Exscientia was acquired by Recursion Pharmaceuticals in August 2024.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide